ask="N/A"
ask_size="N/A"
average_daily_volume="19660"
bid="N/A"
bid_size="N/A"
book_value="0.34"
change="-0.10"
change_from_200_day_moving_average="-0.42"
change_from_50_day_moving_average="-0.51"
change_from_52_week_high="-3.00"
change_From_52_week_low="1.85"
change_in_percent="-1.98%"
close="4.95"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.42"
ebitda="-10.75M"
eps_estimate_current_year="-0.49"
eps_estimate_next_quarter="-0.11"
eps_estimate_next_year="-0.52"
ex_dividend_date="N/A"
float_shares="3528000"
high="5.25"
high_52_weeks="7.95"
last_trade_date="3/13/2017"
last_trade_price="4.95"
last_trade_size="111"
last_trade_time="4:00pm"
low="4.95"
low_52_weeks="3.10"
market_capitalization="145.34M"
moving_average_200_day="5.37"
moving_average_50_day="5.46"
name="OncoCyte Corporation Common Sto"
notes="N/A"
one_year_target_price="10.17"
open="5.15"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-7.78%"
percent_change_from_50_day_moving_average="-9.33%"
percent_change_from_52_week_high="-37.74%"
percent_change_from_52_week_low="+59.68%"
previous_close="5.05"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="14.72"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="29361000"
short_ratio="2.98"
stock_exchange="ASE"
symbol="OCX"
volume="31957"
weeks_range_52="3.10 - 7.95"
